filo Twist Bioscience ( NASDAQ: TWST ) is up ~13% in Monday trading after reporting fiscal 2024 Q4 financial results that beat on both lines and issuing 2025 financial guidance, including revenue. The company sees 2025 revenue of $367M-$377M with a midpoint at $372M. The consensus is $373.
17M..
